Published in BMC Cancer on August 16, 2014
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet (2000) 7.19
Benefits from specialised cancer care. Lancet (1996) 3.08
Health sector accreditation research: a systematic review. Int J Qual Health Care (2008) 2.91
Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ (2012) 2.88
Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol (1993) 1.88
External assessment of health care. BMJ (2001) 1.80
A randomised trial of peer review: the UK National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project. Clin Med (2010) 1.62
Developing the evidence base for accreditation of healthcare organisations: a call for transparency and innovation. Qual Saf Health Care (2009) 1.55
Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer (1993) 1.40
Narrative synthesis of health service accreditation literature. BMJ Qual Saf (2012) 1.27
Improvements in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. Eur J Cancer (2004) 1.20
Specialisation and breast cancer survival in the screening era. Br J Cancer (2003) 1.09
A randomized trial of peer review: the UK National Chronic Obstructive Pulmonary Disease Resources and Outcomes Project: three-year evaluation. J Eval Clin Pract (2011) 1.01
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer (2008) 0.99
The impact of organisational external peer review on colorectal cancer treatment and survival in the Netherlands. Br J Cancer (2014) 0.89
Variation in management of early breast cancer in the Netherlands, 2003-2006. Eur J Surg Oncol (2010) 0.88
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer (2008) 4.41
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER). Lancet Oncol (2007) 3.32
Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer (2011) 2.95
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer. J Natl Cancer Inst (2014) 2.26
A systematic review of web-based interventions for patient empowerment and physical activity in chronic diseases: relevance for cancer survivors. J Med Internet Res (2013) 1.82
Health-related Internet use by patients with somatic diseases: frequency of use and characteristics of users. Inform Health Soc Care (2009) 1.76
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer (2006) 1.55
Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol (2012) 1.51
Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients. J Cancer Surviv (2014) 1.49
[Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients]. Ned Tijdschr Geneeskd (2016) 1.38
Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer (2012) 1.23
Improved survival among younger but not among older patients with Multiple Myeloma in the Netherlands, a population-based study since 1989. Eur J Cancer (2010) 1.21
Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics. Int J Technol Assess Health Care (2009) 1.14
Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer (2008) 1.13
Methodology of constructive technology assessment in health care. Int J Technol Assess Health Care (2007) 1.12
International benchmarking of specialty hospitals. A series of case studies on comprehensive cancer centres. BMC Health Serv Res (2010) 1.12
Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001. Eur J Obstet Gynecol Reprod Biol (2008) 1.05
Critical appraisal of translational research models for suitability in performance assessment of cancer centers. Oncologist (2012) 1.04
Educational needs of general practitioners in palliative care: outcome of a focus group study. J Cancer Educ (2005) 0.98
Successfully improving physical activity behavior after rehabilitation. Am J Health Promot (2007) 0.96
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer (2012) 0.96
Effectiveness of multidimensional cancer survivor rehabilitation and cost-effectiveness of cancer rehabilitation in general: a systematic review. Oncologist (2012) 0.95
Detection of cancer before distant metastasis. BMC Cancer (2013) 0.94
Scenario drafting to anticipate future developments in technology assessment. BMC Res Notes (2012) 0.92
Geographical relationships between sociodemographic factors and incidence of cervical cancer in the Netherlands 1989-2003. Eur J Cancer Prev (2008) 0.90
Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? Int J Cancer (2011) 0.89
Easy navigating through the forest of survivorship care. J Clin Oncol (2013) 0.89
Alpe d'HuZes cancer rehabilitation (A-CaRe) research: four randomized controlled exercise trials and economic evaluations in cancer patients and survivors. Int J Behav Med (2012) 0.87
A review on the relation between simulation and improvement in hospitals. BMC Med Inform Decis Mak (2012) 0.86
Age-specific differences in the treatment of cervical cancer in the east and the south of The Netherlands 1989-2004. Eur J Obstet Gynecol Reprod Biol (2009) 0.85
Empowerment of Cancer Survivors Through Information Technology: An Integrative Review. J Med Internet Res (2015) 0.85
A web-based communication system for integrated care in cerebral palsy: design features, technical feasibility and usability. J Telemed Telecare (2010) 0.85
Assessment of cancer risks due to environmental exposure to asbestos. J Expo Sci Environ Epidemiol (2009) 0.84
Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up. Mov Disord (2004) 0.84
Exploring improvements in patient logistics in Dutch hospitals with a survey. BMC Health Serv Res (2012) 0.84
Underlying mechanisms of improving physical activity behavior after rehabilitation. Int J Behav Med (2008) 0.84
Disparities in survival of stomach cancer among different socioeconomic groups in North-East Netherlands. Cancer Epidemiol (2011) 0.84
Intra-organizational dynamics as drivers of entrepreneurship among physicians and managers in hospitals of western countries. Soc Sci Med (2012) 0.84
A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy. BMC Cancer (2011) 0.83
Review on early technology assessments of nanotechnologies in oncology. Mol Oncol (2009) 0.83
Early-stage young breast cancer patients: impact of local treatment on survival. Int J Radiat Oncol Biol Phys (2011) 0.83
Quantifying culture gaps between physicians and managers in Dutch hospitals: a survey. BMC Health Serv Res (2010) 0.82
Vaginal and (uncommon) cervical cancers in the Netherlands, 1989-2003. Int J Gynecol Cancer (2010) 0.82
The number of metastatic sites for stage IIIA endometrial carcinoma, endometrioid cell type, is a strong negative prognostic factor. Gynecol Oncol (2010) 0.82
Availability of stage at diagnosis, cancer treatment delay and compliance with cancer guidelines as cancer registry indicators for cancer care in Europe: Results of EUROCHIP-3 survey. Int J Cancer (2012) 0.82
Development of MijnAVL, an Interactive Portal to Empower Breast and Lung Cancer Survivors: An Iterative, Multi-Stakeholder Approach. JMIR Res Protoc (2015) 0.81
Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only. Obstet Gynecol Int (2011) 0.81
An interactive portal to empower cancer survivors: a qualitative study on user expectations. Support Care Cancer (2015) 0.81
A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making. Breast (2013) 0.81
Diverging breast and stomach cancer incidence and survival in migrants in The Netherlands, 1996-2009. Acta Oncol (2012) 0.80
Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance. Breast Cancer Res Treat (2011) 0.80
Histological type is not an independent prognostic factor for the risk pattern of breast cancer recurrences. Breast Cancer Res Treat (2012) 0.80
Does lowering the screening age for cervical cancer in The Netherlands make sense? Int J Cancer (2008) 0.80
Accounting for inpatient wards when developing master surgical schedules. Anesth Analg (2011) 0.80
Value of research and value of development in early assessments of new medical technologies. Value Health (2013) 0.79
Attending the breast screening programme after breast cancer treatment: a population-based study. Cancer Epidemiol (2013) 0.79
Tumour tissue: who is in control? Lancet Oncol (2009) 0.78
[Resection of liver metastases in breast cancer]. Ned Tijdschr Geneeskd (2015) 0.78
Pattern of follow-up care and early relapse detection in breast cancer patients. Breast Cancer Res Treat (2012) 0.78
[Percentage of local recurrence following treatment for breast cancer is not a suitable performance indicator]. Ned Tijdschr Geneeskd (2010) 0.77
Physician' entrepreneurship explained: a case study of intra-organizational dynamics in Dutch hospitals and specialty clinics. Hum Resour Health (2014) 0.77
Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients. Breast Cancer Res Treat (2015) 0.77
Association between genomic recurrence risk and well-being among breast cancer patients. BMC Cancer (2013) 0.77
Retracted Breast and stomach cancer incidence and survival in migrants in the Netherlands, 1996-2006. Eur J Cancer Prev (2011) 0.77
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project. Cancer Epidemiol (2013) 0.76
Determinants of use and non-use of a web-based communication system in cerebral palsy care: evaluating the association between professionals' system use and their a priori expectancies and background. BMC Med Inform Decis Mak (2011) 0.75
Exploring types of focused factories in hospital care: a multiple case study. BMC Health Serv Res (2010) 0.75
Use of trastuzumab for HER2-positive metastatic breast cancer in daily practice: a population-based study focusing on the elderly. Anticancer Drugs (2016) 0.75
Long-term effects of a regional care pathway for patients with rectal cancer. Int J Colorectal Dis (2015) 0.75
Immediate Breast Reconstruction in The Netherlands and the United States: A Proof-of-Concept to Internationally Compare Quality of Care Using Cancer Registry Data. Plast Reconstr Surg (2019) 0.75
Factors Associated with the Use of Gene Expression Profiles in Estrogen Receptor-Positive Early-Stage Breast Cancer Patients: A Nationwide Study. Public Health Genomics (2016) 0.75
[The value of ipsilateral breast tumor recurrence as a quality indicator: hospital variation in the Netherlands]. Ned Tijdschr Geneeskd (2015) 0.75
Reducing the throughput time of the diagnostic track involving CT scanning with computer simulation. Eur J Radiol (2012) 0.75
Do screen-detected breast cancers have positive margins less often than clinically detected breast cancers? Eur J Cancer Prev (2013) 0.75
Evaluating the impact of accreditation and external peer review. Int J Health Care Qual Assur (2015) 0.75